Aspirin and Clopidogrel Resistance; a Neglected Gap in Stroke and Cardiovascular Practice in Iran: a Systematic Review and Meta-analysis

Overview

Journal Thromb J

Publisher Biomed Central

Date 2023 Jul 27

PMID 37501091

Authors

Mohammad Parsa-Kondelaji

Hassan Mansouritorghabeh

Affiliations

Soon will be listed here.

Abstract

Objective: Antiplatelet drugs, such as Aspirin and Clopidogrel (Plavix) are effective in the primary prevention of thromboembolic events. They are commonly used to reduce the risk of recurrence of thromboembolism. The body's hemostatic system responds differently to these drugs in different people. Resistance testing for aspirin and Clopidogrel is now recommended before starting antiplatelet therapy.

Methods: A systematic literature search was performed on May 12, 2021, using the medical search engines PubMed, Scopus, and Web of Science, and the local databases SID and Magiran. After data extraction, a meta-analysis was performed using Comprehensive Meta-Analysis (CMA2) software. The I2 statistic was used to measure heterogeneity between estimates.

Results: Among the 949 papers, Clopidogrel resistance was assessed in 136 patients and Aspirin resistance in 400 patients. The prevalence of Aspirin resistance was found to be 52.1% and the prevalence of Clopidogrel resistance was found to be 20.5%.

Conclusion: It seems that in Iran, the issue of Aspirin and Clopidogrel resistance is suboptimally addressed. This pattern could also occur in other developing countries in the Middle East region.

Citing Articles

The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients.

Poparn H, Kittikalayawong Y, Techavichit P, Lauhasurayotin S, Chiengthong K, Chaweephisal P Pediatric Health Med Ther. 2024; 15:333-338.

PMID: 39559403 PMC: 11571927. DOI: 10.2147/PHMT.S478540.

Assessment of Aspirin and Clopidogrel Resistance in Patients Undergoing Cardiovascular Surgery: A Single-Center Cross-Sectional Study.

Ozer A, Demirtas H, Tak S, Kocak B, Yigiter E, Oktar G Turk J Haematol. 2024; 41(2):105-112.

PMID: 38501691 PMC: 11589263. DOI: 10.4274/tjh.galenos.2024.2024.0043.

Flow diversion of ruptured intracranial aneurysms: a single-center study with a standardized antithrombotic treatment protocol.

Rantamo A, Galle C, Numminen J, Virta J, Tanskanen P, Lindroos A Acta Neurochir (Wien). 2024; 166(1):130.

PMID: 38467916 PMC: 10927838. DOI: 10.1007/s00701-024-06029-7.

Genetics in Ischemic Stroke: Current Perspectives and Future Directions.

Zhang K, Loong S, Yuen L, Venketasubramanian N, Chin H, Lai P J Cardiovasc Dev Dis. 2023; 10(12).

PMID: 38132662 PMC: 10743455. DOI: 10.3390/jcdd10120495.

References

Haji Aghajani M, Kobarfard F, Shojaei S, Ahmadpour F, Safi O, Kazemina N . The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention. Iran J Pharm Res. 2018; 17(3):1099-1104. PMC: 6094421. View

Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B . Clinical importance of aspirin and clopidogrel resistance. World J Cardiol. 2010; 2(7):171-86. PMC: 2998916. DOI: 10.4330/wjc.v2.i7.171. View

Gersh B, Sliwa K, Mayosi B, Yusuf S . Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010; 31(6):642-8. DOI: 10.1093/eurheartj/ehq030. View

Bishopric N . Toward a genomic definition of aspirin resistance. J Am Coll Cardiol. 2013; 62(14):1277-1279. DOI: 10.1016/j.jacc.2013.06.024. View

Eskandarian R, Darabian M, Heshmatnia J, Ghorbani R . Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors. Saudi Med J. 2012; 33(1):39-43. View

Kojuri J, Mahmoody Y, Zangbar Sabegh B, Jannati M, Mahboodi A, Khalili A . Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. Cardiovasc Ther. 2010; 28(3):147-52. DOI: 10.1111/j.1755-5922.2010.00170.x. View

Du G, Lin Q, Wang J . A brief review on the mechanisms of aspirin resistance. Int J Cardiol. 2016; 220:21-6. DOI: 10.1016/j.ijcard.2016.06.104. View

Guirgis M, Thompson P, Jansen S . Review of aspirin and clopidogrel resistance in peripheral arterial disease. J Vasc Surg. 2017; 66(5):1576-1586. DOI: 10.1016/j.jvs.2017.07.065. View

Awtry E, Loscalzo J . Aspirin. Circulation. 2000; 101(10):1206-18. DOI: 10.1161/01.cir.101.10.1206. View

10.

Wang T, Bhatt D, Topol E . Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J. 2005; 27(6):647-54. DOI: 10.1093/eurheartj/ehi684. View

11.

Cattaneo M . Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol. 2004; 24(11):1980-7. DOI: 10.1161/01.ATV.0000145980.39477.a9. View

12.

FitzGerald R, Pirmohamed M . Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther. 2011; 130(2):213-25. DOI: 10.1016/j.pharmthera.2011.01.011. View

13.

Haji Aghajani M, Kobarfard F, Safi O, Sheibani K, Sistanizad M . Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention. Iran J Pharm Res. 2013; 12(Suppl):169-74. PMC: 3813374. View

14.

Rowland M, RIEGELMAN S, Harris P, Sholkoff S . Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci. 1972; 61(3):379-85. DOI: 10.1002/jps.2600610312. View

15.

Perrier-Cornet A, Ianotto J, Mingant F, Perrot M, Lippert E, Galinat H . Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms. Platelets. 2017; 29(7):723-728. DOI: 10.1080/09537104.2017.1361018. View

16.

Crofford L . COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997; 49:15-9. View

17.

Helgason C, Bolin K, Hoff J, Winkler S, Mangat A, Tortorice K . Development of aspirin resistance in persons with previous ischemic stroke. Stroke. 1994; 25(12):2331-6. DOI: 10.1161/01.str.25.12.2331. View

18.

Navaratnam K, Alfirevic A, Alfirevic Z . Low dose aspirin and pregnancy: how important is aspirin resistance?. BJOG. 2016; 123(9):1481-7. PMC: 5069612. DOI: 10.1111/1471-0528.13914. View

19.

Mirzaei H, Abdi Z, Ahmadnezhad E, Gohrimehr M, Abdalmaleki E, Alvandi R . Health Status in the Islamic Republic of Iran, Middle East and North Africa Countries: Implications for Global Health. Iran J Public Health. 2020; 49(1):86-95. PMC: 7152645. View

20.

Sadeghi M, Emami A, Ziyaei N, Yaran M, Golabchi A, Sadeghi A . Aspirin resistance and ischemic heart disease on Iranian experience. Adv Biomed Res. 2012; 1:33. PMC: 3507033. DOI: 10.4103/2277-9175.99345. View